Ti=Statutory and {_NIH} Requirements and Reserved Government Rights

1.1.sec={_IC} reserves on behalf of the {_Government} an irrevocable, nonexclusive, nontransferable, royalty free license for the practice of all inventions licensed under the {_Licensed_Patent_Rights} throughout the world by or on behalf of the {_Government} and on behalf of any foreign government or international organization pursuant to any existing or future treaty or agreement to which the {_Government} is a signatory.  Prior to the {_First_Commercial_Sale},  {_Licensee} agrees to provide {_IC} with reasonable quantities of the {_Licensed_Products} or materials made through the {_Licensed_Processes} for {_IC} research use; and

1.2.sec=in the event that the {_Licensed_Patent_Rights} are Subject Inventions made under {_CRADA}, {_Licensee} grants to the {_Government}, pursuant to 15 U.S.C. §3710a(b)(1)(A), a nonexclusive, nontransferable, irrevocable, paid up license to practice the {_Licensed_Patent_Rights} or have the {_Licensed_Patent_Rights} practiced throughout the world by or on behalf of the {_Government}.  In the exercise of this license, the {_Government} shall not publicly disclose trade secrets or commercial or financial information that is privileged or confidential within the meaning of 5 U.S.C. §552(b)(4) or which would be considered as such if it had been obtained from a non Federal party.  Prior to the {_First_Commercial_Sale}, {_Licensee} agrees to provide {_IC} with reasonable quantities of the {_Licensed_Products} or materials made through the {_Licensed_Processes} for {_IC} research use.

1.=[G/Z/ol/s2]

2.sec={_Licensee} agrees that products used or sold in the United States embodying the {_Licensed_Products} or produced through use of the {_Licensed_Processes} shall be manufactured substantially in the United States, unless a written waiver is obtained in advance from {_IC}.

3.sec={_Licensee} acknowledges that {_IC} may enter into future {_CRADA}s under the Federal Technology Transfer Act of 1986 that relate to the subject matter of {_this_Agreement}.  {_Licensee} agrees not to unreasonably deny requests for a {_Research_License} from future collaborators with {_IC} when acquiring these rights is necessary in order to make a {_CRADA} project feasible.  {_Licensee} may request an opportunity to join as a party to the proposed {_CRADA}.

4.1.sec=in addition to the reserved license of Paragraph 5.1, {_IC} reserves the right to 	grant {_Research_License}s directly or to require {_Licensee} to grant Research 	Licenses on reasonable terms.  The purpose of these {_Research_License}s is to 	encourage basic research, whether conducted at an academic or corporate 	facility.  In order to safeguard the {_Licensed_Patent_Rights}, however, {_IC} 	shall consult with {_Licensee} before granting to commercial entities a 	{_Research_License} or providing to them research samples of materials made 	through the {_Licensed_Processes}; and

4.2.0.sec=in exceptional circumstances, and in the event that the {_Licensed_Patent_Rights} are Subject Inventions made under a {_CRADA}, the {_Government}, pursuant to 15 U.S.C. §3710a(b)(1)(B), retains the right to require {_Licensee} to grant to a responsible applicant a nonexclusive, partially exclusive, or exclusive sublicense to use the {_Licensed_Patent_Rights} in the Licensed Field of Use on terms that are reasonable under the circumstances, or if {_Licensee} fails to grant this license, the {_Government} retains the right to grant the license itself.  The exercise of these rights by the {_Government} shall only be in exceptional circumstances and only if the {_Government} determines:

4.2.1.sec=the action is necessary to meet health or safety needs that are not reasonably satisfied by {_Licensee};

4.2.2.sec=the action is necessary to meet requirements for public use specified by Federal regulations, and these requirements are not reasonably satisfied by {_Licensee}; or

4.2.3.sec={_Licensee} has failed to comply with an agreement containing provisions described in 15 U.S.C. §3710a(c)(4)(B); and

4.2.=[G/Z/ol-i/s3]

4.3.sec=the determination made by the {_Government} under this Paragraph 5.4 is subject to administrative appeal and judicial review under 35 U.S.C. §203(b).

4.=[G/Z/ol-a/s3]

=[G/Z/ol/s4]
